Hamilton Point Investment Advisors LLC lifted its holdings in shares of Danaher Co. (NYSE:DHR) by 4.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 42,039 shares of the conglomerate’s stock after buying an additional 1,905 shares during the quarter. Danaher comprises approximately 2.2% of Hamilton Point Investment Advisors LLC’s investment portfolio, making the stock its 14th biggest holding. Hamilton Point Investment Advisors LLC’s holdings in Danaher were worth $4,342,000 at the end of the most recent quarter.
Several other large investors have also modified their holdings of DHR. Ruggie Capital Group acquired a new stake in shares of Danaher during the 4th quarter worth approximately $40,000. We Are One Seven LLC acquired a new stake in shares of Danaher during the 4th quarter worth approximately $44,000. Legacy Financial Advisors Inc. grew its position in shares of Danaher by 59.4% during the 4th quarter. Legacy Financial Advisors Inc. now owns 690 shares of the conglomerate’s stock worth $71,000 after buying an additional 257 shares during the period. NuWave Investment Management LLC grew its position in shares of Danaher by 5,600.0% during the 4th quarter. NuWave Investment Management LLC now owns 798 shares of the conglomerate’s stock worth $82,000 after buying an additional 784 shares during the period. Finally, Parkside Financial Bank & Trust grew its position in shares of Danaher by 76.7% during the 4th quarter. Parkside Financial Bank & Trust now owns 1,016 shares of the conglomerate’s stock worth $105,000 after buying an additional 441 shares during the period. Institutional investors own 77.79% of the company’s stock.
DHR opened at $109.25 on Monday. Danaher Co. has a twelve month low of $91.84 and a twelve month high of $111.10. The company has a debt-to-equity ratio of 0.34, a current ratio of 1.47 and a quick ratio of 1.07. The stock has a market cap of $76.57 billion, a P/E ratio of 24.17, a PEG ratio of 2.01 and a beta of 0.99.
The company also recently disclosed a quarterly dividend, which was paid on Friday, January 25th. Investors of record on Friday, December 28th were given a dividend of $0.16 per share. The ex-dividend date of this dividend was Thursday, December 27th. This represents a $0.64 annualized dividend and a yield of 0.59%. Danaher’s dividend payout ratio is 14.16%.
Several brokerages have recently commented on DHR. Cowen reiterated a “buy” rating and set a $110.00 price target on shares of Danaher in a research report on Monday, January 7th. Needham & Company LLC assumed coverage on shares of Danaher in a research note on Wednesday, January 2nd. They set a “buy” rating and a $114.00 price objective on the stock. Royal Bank of Canada reissued a “hold” rating and set a $102.00 price objective on shares of Danaher in a research note on Wednesday, December 19th. Finally, Robert W. Baird reduced their price objective on shares of Danaher from $116.00 to $114.00 and set an “outperform” rating on the stock in a research note on Friday, October 19th. Two equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus target price of $113.08.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.
Recommended Story: Bollinger Bands
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.